Bank of America lifted its price objective and issued a 'buy' rating for BridgeBio Pharma, concurrent with a required institutional investment filing.

The entities involved

• Bank of America →

  American multinational banking and financial services corporation

  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
  • Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Financial institutions, including Wells Fargo and Bank of America, issued rating updates and filed reports regarding institutional stake reductions with the SEC.Aug 17
• Bank of America and Raymond James Financial raised their ratings and increased price targets for Okta.Aug 30
• Bank of America restated a buy rating on an unnamed company on August 17, 2026.Aug 17
• Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.Sat 10:54
• Analyst rating changes for Salesforce, including buy rating upgrades and coverage initiation, were reported on July 18, 2026.Jul 18